News

CQDM is proud to announce the funding of two collaborative research projects related to the development of RNA therapies. This announcement marks the allocation of a total financial support of $700,844, granted by the Government of Quebec via CQDM's SynergiQc program. These two projects exemplify the exceptional vitality of Quebec's biotechnology ecosystem and the inventiveness of Quebec researchers.

Molecular Forecaster Inc. (MFI) and TransBIOTech are pleased to announce a strategic partnership leveraging the complementary strengths of both organizations to develop drug discovery programs that combine MFI's customized Computer-Aided Drug Design (CADD) solutions with TransBIOTech's in vitro and in vivo expertise.

This multi-year funding aims to advance promising cancer therapies by conducting preclinical toxicity and efficacy studies required for regulatory approvals for clinical trials.